In this context, receptor tyrosine kinase‐like orphan receptor 1 (ROR1), previously associated with poor prognosis and targeted therapeutically in other malignancies, has not yet been investigated in cSCC. This evidence concerns the gene ROR1 and skin squamous cell carcinoma.